金山科研平台，产品价格货期咨询微信：jinshanbio Source:Mouse myeloma cell line, NS0-derived, Lys24-Cys92 Accession #:P10146 N-terminal Sequence Analysis:Lys24 Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:7.8 kDa SDS-PAGE:13-16 kDa, reducing conditions Activity:Measured by its ability to chemoattract BW5147 mouse T lymphoma cells.The ED₅₀ for this effect is typically 3-9ng/mL.Measured by its ability to chemoattract BaF3 mouse pro‑B cells transfected with mouse CCR8.The ED₅₀ for this effect is typically 0.5 - 2.0 ng/mL. Molecule Information: CCL1/I-309/TCA-3 Aliases: I-309; P500; SCYA1; SCYA2; TCA-3 Entrez Gene IDs: 6346 (Human); 20290 (Mouse) Background: CCL1/I-309/TCA-3 I-309, a member of the CC subfamily of chemokines, was initially identified by subtractive hybridization as a transcript that was present in a gamma/delta T cell line, but not in EBV-transformed B cells. Human I-309 is assumed to be a homolog of the mouse TCA-3. While the two proteins share only approximately 42% amino acid sequence identity, both chemokines contain an extra pair of cysteine residues not found in most other chemokines.